These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21701301)

  • 1. Use of botulinum toxin (botox) in the management of masseter muscle hypertrophy: a simplified technique.
    Andrade NN; Deshpande GS
    Plast Reconstr Surg; 2011 Jul; 128(1):24e-26e. PubMed ID: 21701301
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional stereophotogrammetric method of quantifying the effect of botulinum toxin type A injections on masseter hypertrophy.
    Adriaens J; van Loon B; Ingels KJ; Bergé SJ; Maal TJ
    Plast Reconstr Surg; 2012 Aug; 130(2):376e-378e. PubMed ID: 22842446
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK; Tan FU; Kendi T; Koc C
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aesthetic uses of botulinum toxin A.
    Niamtu J
    J Oral Maxillofac Surg; 1999 Oct; 57(10):1228-33. PubMed ID: 10513870
    [No Abstract]   [Full Text] [Related]  

  • 10. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
    No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
    J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
    Aydil B; Başaran B; Unsaler S; Süoğlu Y
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC
    Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.
    Mandel L; Tharakan M
    J Oral Maxillofac Surg; 1999 Aug; 57(8):1017-9. PubMed ID: 10437733
    [No Abstract]   [Full Text] [Related]  

  • 14. Unilateral masseter muscle hypertrophy: morphofunctional analysis of the relapse after treatment with botulinum toxin.
    Peretta R; Melison M; Meneghello R; Comelli D; Guarda L; Galzignato PF; Concheri G; Ferronato G
    Cranio; 2009 Jul; 27(3):200-10. PubMed ID: 19697649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Simple Botulinum Toxin Injection Technique for Masseter Reduction.
    Ng ZY; Yang T
    Aesthet Surg J; 2021 Nov; 41(12):NP2104-NP2105. PubMed ID: 34223879
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
    J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
    Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masseteric hypertrophy: considerations regarding treatment planning decisions and introduction of a novel surgical technique.
    Pary A; Pary K
    J Oral Maxillofac Surg; 2011 Mar; 69(3):944-9. PubMed ID: 21195532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
    Xue Z; Zeng W; Chen Z; Han Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.